4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0000950170-25-068281
Chief Financial Officer bought 8,462 shares at $26.00 ($220,012)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Byam Rebecca Chief Financial Officer | 2025-05-08 | Purchase | +8,462 | $26.00 | $220,012 | 43,010 | D: show line 1 in the form |
| Open-market purchases · 8,462 sh · avg $26.00 · $220,012 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Byam Rebecca Chief Financial Officer | 2025-05-07 | Purchase · Common Stock Purchase Warrant | +4,231 | 4,231 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…